Literature DB >> 900915

Comparative pharmacology of cefaclor and cephalexin.

O M Korzeniowski, W M Scheld, M A Sande.   

Abstract

Two cephalosporin antibiotics, cefaclor and cephalexin, were administered orally to healthy, adult male volunteers for comparison of their pharmacological properties. In doses of 250 mg orally, cefaclor produced a peak serum concentration of 6.01 +/- 0.55 (standard deviation [SD]) mug/ml compared with 9.43 +/- 2.36 mug/ml for cephalexin (P < 0.01). The half-lives were 0.58 +/- 0.07 (SD) h and 0.80 +/- 0.12 (SD) h, and elimination constants were 1.22 +/- 0.15 and 0.88 +/- 0.13 h(-1) for cefaclor and cephalexin, respectively (P < 0.001). Neither drug showed accumulation over the dosing period, and both were well tolerated.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 900915      PMCID: PMC429879          DOI: 10.1128/AAC.12.2.157

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  5 in total

Review 1.  The cephalosporin group of antibiotics.

Authors:  D R Owens; D K Luscombe; A D Russell; P J Nicholls
Journal:  Adv Pharmacol Chemother       Date:  1975

Review 2.  Pharmacokinetics and clinical use of cephalosporin antibiotics.

Authors:  C H Nightingale; D S Greene; R Quintiliani
Journal:  J Pharm Sci       Date:  1975-12       Impact factor: 3.534

3.  Metabolism of (14C) cefaclor, a cephalosporin antibiotic, in three species of laboratory animals.

Authors:  H R Sullivan; S L Due; D L Kau; J F Quay; W Miller
Journal:  Antimicrob Agents Chemother       Date:  1976-10       Impact factor: 5.191

4.  In vitro susceptibility studies with cefaclor and cephalexin.

Authors:  W M Scheld; O M Korzeniowski; M A Sande
Journal:  Antimicrob Agents Chemother       Date:  1977-08       Impact factor: 5.191

5.  Simplified, accurate method for antibiotic assay of clinical specimens.

Authors:  J V Bennett; J L Brodie; E J Benner; W M Kirby
Journal:  Appl Microbiol       Date:  1966-03
  5 in total
  18 in total

1.  Efficacy of a new cream formulation of mupirocin: comparison with oral and topical agents in experimental skin infections.

Authors:  J Gisby; J Bryant
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

2.  Pharmacokinetics of cefuroxime axetil and cefaclor: relationship of concentrations in serum to MICs for common respiratory pathogens.

Authors:  N C James; K H Donn; J J Collins; I M Davis; T L Lloyd; R W Hart; J R Powell
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191

3.  In vitro susceptibility studies with cefaclor and cephalexin.

Authors:  W M Scheld; O M Korzeniowski; M A Sande
Journal:  Antimicrob Agents Chemother       Date:  1977-08       Impact factor: 5.191

4.  Cefaclor: summary of clinical experience.

Authors:  R B Kammer; L J Short
Journal:  Infection       Date:  1979       Impact factor: 3.553

5.  Penetration of cefaclor into bronchial mucosa.

Authors:  G E Marlin; A J Nicholls; G R Funnell; R Bradbury
Journal:  Thorax       Date:  1984-11       Impact factor: 9.139

6.  Cefaclor pharmacokinetic parameters: serum concentrations determined by a new high-performance liquid chromatographic technique.

Authors:  J C Rotschafer; K B Crossley; T S Lesar; D Zaske; K Miller
Journal:  Antimicrob Agents Chemother       Date:  1982-01       Impact factor: 5.191

7.  Concentration relationships of cefaclor in serum, interstitial fluid, bile, and urine of dogs.

Authors:  N G Waterman; L F Scharfenberger
Journal:  Antimicrob Agents Chemother       Date:  1978-10       Impact factor: 5.191

8.  Comparative pharmacokinetics of cephalexin, cefaclor, cefadroxil, and CGP 9000.

Authors:  H Lode; R Stahlmann; P Koeppe
Journal:  Antimicrob Agents Chemother       Date:  1979-07       Impact factor: 5.191

9.  Pharmacokinetics of cefaclor and cephalexin: dosage nomograms for impaired renal function.

Authors:  D A Spyker; B L Thomas; M A Sande; W K Bolton
Journal:  Antimicrob Agents Chemother       Date:  1978-08       Impact factor: 5.191

10.  Interethnic differences of PEPT2 (SLC15A2) polymorphism distribution and associations with cephalexin pharmacokinetics in healthy Asian subjects.

Authors:  Rui Liu; Audrey May Yi Tang; Yen Ling Tan; Lie Michael George Limenta; Edmund Jon Deoon Lee
Journal:  Eur J Clin Pharmacol       Date:  2008-09-03       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.